Oncology and reproductive outcomes over 16 years of malignant ovarian germ cell tumors treated by fertility sparing surgery

doi:10.5306/wjco.v13.i10.802

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3341)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

116

WORD

HTML

1212

Figures (1-2)

223

Tables (1-5)

206

Sum=1782

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

220

Download

716

Sum=936

Publishing Process of This Article

Item

Count

Browse

147

Download

476

Sum=623

Oct 24, 2022 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Oct 24, 2022; 13(10): 802-812
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.802

Table 3 Menstrual data of studied patients who received chemotherapy (n = 43)

	n (%)
No menstruation after treatment	8 (18.6)
No menarche¹	1
Premature menopause	7
Resume menstruation²	17 (39.5)
1 mo	2
2 mo	2
3 mo	2
4 mo	3
5 mo	1
6 mo	6
Median 4 mo (1-6)
Menstruation during and post-treatment	18 (41.9)

¹SN 4, no menarche at age 12 years old.

²SN 64, menarche at age 12.

Citation: Rungoutok M, Suprasert P. Oncology and reproductive outcomes over 16 years of malignant ovarian germ cell tumors treated by fertility sparing surgery. World J Clin Oncol 2022; 13(10): 802-812
URL: https://www.wjgnet.com/2218-4333/full/v13/i10/802.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i10.802